| Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions VM Orellana-Noia, DR Reed, AA McCook, JM Sen, CM Barlow, ... Blood, The Journal of the American Society of Hematology 139 (3), 413-423, 2022 | 89 | 2022 |
| State abortion policies and Medicaid coverage of abortion are associated with pregnancy outcomes among individuals seeking abortion recruited using Google Ads: a national … UD Upadhyay, AA McCook, AH Bennett, AF Cartwright, SCM Roberts Social Science & Medicine 274, 113747, 2021 | 48 | 2021 |
| Humoral responses against SARS-CoV-2 and variants of concern after mRNA vaccines in patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia A Chang, A Akhtar, SL Linderman, L Lai, VM Orellana-Noia, ... Journal of Clinical Oncology 40 (26), 3020-3031, 2022 | 42 | 2022 |
| Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial NF Saba, CE Steuer, A Ekpenyong, A McCook-Veal, K Magliocca, M Patel, ... Nature medicine 29 (4), 880-887, 2023 | 41 | 2023 |
| Antibody response to COVID-19 mRNA vaccine in patients with lung cancer after primary immunization and booster: reactivity to the SARS-CoV-2 WT virus and omicron variant RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ... Journal of Clinical Oncology 40 (33), 3808-3816, 2022 | 33 | 2022 |
| Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: reactivity to vaccine antigen and variants of concern RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ... MedRxiv, 2022.01. 03.22268599, 2022 | 14 | 2022 |
| A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC). NF Saba, A Ekpenyong, A McCook-Veal, M Patel, NC Schmitt, WA Stokes, ... Journal of Clinical Oncology 40 (16_suppl), 6008-6008, 2022 | 12 | 2022 |
| Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study PB Allen, AA McCook‐Veal, JM Switchenko, DM Paulino, T Niyogusaba, ... Cancer 129 (4), 541-550, 2023 | 8 | 2023 |
| Antibody binding and neutralization of live SARS-CoV-2 variants including BA. 4/5 following booster vaccination of patients with B-cell malignancies A Chang, A Akhtar, L Lai, VM Orellana-Noia, SL Linderman, ... Cancer research communications 2 (12), 1684-1692, 2022 | 5 | 2022 |
| Surgery in combination with systemic chemotherapy is associated with improved survival in stage IV gallbladder cancer AS Casabianca, V Tsagkalidis, PR Burchard, A Chacon, A Melucci, ... European Journal of Surgical Oncology 48 (12), 2448-2454, 2022 | 5 | 2022 |
| Characterizing outcomes in visceral cutaneous T-cell lymphoma: a single center retrospective study TZ Zhuang, A McCook-Veal, J Switchenko, T Niyogusaba, ES Tarabadkar, ... Clinical Lymphoma Myeloma and Leukemia 23 (9), 667-673, 2023 | 4 | 2023 |
| Nipavect: Phase II study of niraparib and panitumumab in advanced RAS WT colorectal cancer. OB Alese, M Diab, OB Gbolahan, A McCook-Veal, WL Shaib, C Wu, ... Journal of Clinical Oncology 41 (16_suppl), 3579-3579, 2023 | 4 | 2023 |
| Incidence and predictors of toxicity in the management of vulvar squamous cell carcinoma treated with radiation therapy NS McCall, TY Eng, JW Shelton, S Hanasoge, PR Patel, AB Patel Jr, ... Gynecologic Oncology Reports 44, 101086, 2022 | 4 | 2022 |
| BA. 5 bivalent booster vaccination enhances neutralization of XBB. 1.5, XBB. 1.16 and XBB. 1.9 variants in patients with lung cancer RM Valanparambil, L Lai, MA Johns, M Davis-Gardner, SL Linderman, ... npj Vaccines 8 (1), 179, 2023 | 3 | 2023 |
| Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors S Kang, L Khalil, A Mccook‐Veal, Y Liu, J Galvin, A Draper, N Kokabi, ... Liver Cancer International 4 (2), 77-88, 2023 | 3 | 2023 |
| CA209-9KY: Results of a phase II study of intensity modulated radiotherapy (IMRT) re-irradiation and concurrent/adjuvant nivolumab (nivo) in patients with loco-regionally … NF Saba, MW McDonald, A McCook-Veal, WA Stokes, T Nasti, S Rudra, ... Journal of Clinical Oncology 40 (16_suppl), 6029-6029, 2022 | 3 | 2022 |
| Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis NF Saba, R Chaudhary, K Kirtane, A Marra, A Ekpenyong, ... Clinical Cancer Research 30 (20), 4601-4608, 2024 | 2 | 2024 |
| Intensity-modulated reirradiation therapy with nivolumab in recurrent or second primary head and neck squamous cell carcinoma: a nonrandomized controlled trial NF Saba, SJ Wong, T Nasti, AA McCook-Veal, MW McDonald, WA Stokes, ... JAMA oncology 10 (7), 896-904, 2024 | 2 | 2024 |
| Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors. L Khalil, S Kang, A McCook-Veal, A Draper, M Diab, WL Shaib, OB Alese, ... Journal of Clinical Oncology 40 (16_suppl), 4118-4118, 2022 | 2 | 2022 |
| Risk factors for progression from early to advanced stage mycosis fungoides: a single center retrospective analysis at the Winship Cancer Institute of Emory University P Allen, AA McCook, JM Switchenko, S Varma, MJ Lechowicz, ... Blood 138, 1378, 2021 | 2 | 2021 |
